Cargando…
Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases
BACKGROUND: Several studies have shown that the immunophenotype of distant breast cancer metastases may differ significantly from that of the primary tumor, especially with regard to differences in the level of hormone receptor protein expression, a process known as receptor conversion. This study a...
Autores principales: | Jiwa, Laura S, van Diest, Paul J, Hoefnagel, Laurien D, Wesseling, Jelle, Wesseling, Pieter, Moelans, Cathy B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247109/ https://www.ncbi.nlm.nih.gov/pubmed/25417118 http://dx.doi.org/10.1186/1471-2407-14-864 |
Ejemplares similares
-
Receptor conversion in distant breast cancer metastases
por: Hoefnagel, Laurien DC, et al.
Publicado: (2010) -
Promoter hypermethylation profiling of distant breast cancer metastases
por: Schrijver, Willemijne A. M. E., et al.
Publicado: (2015) -
The prognostic effect of DDX3 upregulation in distant breast cancer metastases
por: Heerma van Voss, Marise R., et al.
Publicado: (2016) -
PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy
por: Beelen, Karin, et al.
Publicado: (2014) -
The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma
por: Kim, Sewha, et al.
Publicado: (2013)